Groowe Groowe / Newsroom / GSK
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

GSK News

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL

businesswire.com
GSK NUVL

The Franklin Institute and GSK Celebrate 40 Years of GSK Science in the Summerâ„¢ with New "Be A Chemist!" Theme and Program Expansion

prnewswire.com
GSK

Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight

globenewswire.com
RAPT SANG INCY ABBV ARCT AMGN CHKP PFE LLY SCLX SNY UCB BIIB NVS VTRS BMY ABSI ALEC GSK IONS CLNN ANNX MED GAM VRTX EXC BLRX

Perseus Information Security Consulting Becomes Fully Accredited Certification Body for ISASecure ACSSA Program

prnewswire.com
HON JCI SWKS AMZN SNPS CDNS NVDA AMD INTC MSFT GOOGL IBM CSCO PANW CRWD FTNT DDOG PLTR SNOW ADBE ORCL SAP CRM NOW MRVL QCOM MU AMAT LRCX KLAC ASML TXN ADI NXPI ON INFY CTSH ACN HPQ DELL MSI AVGO MCHP STM RELI XOM CVX SHEL GSK YPF BVS CAR SE

Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates

globenewswire.com
NTHI GSK NUVL PFE

Sedai Launches the First Autonomous Platform for AI Agent Optimization

prnewswire.com
GSK KNSL

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

globenewswire.com
GSK

IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight

globenewswire.com
AMRX ARX GSK AZN SNY NVS MRK REGN JNJ PFE BMY LLY VRTX AMGN ABBV GILD BIIB CSL AQST RAPT ALGT

Altesa BioSciences Appoints Brett Haumann, MBBCh, MBA, to its Board of Directors and Gwen Skloot, MD, ATSF, as Senior Vice President for Clinical Development

prnewswire.com
RIGL GSK

Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
KURA BMY IPHA MRK MNPR JAZZ MOLN LLY GSK AGEN PFE